Identification and differentiation of Candida parapsilosis complex species by use of exon-primed intron-crossing PCR

Area of Science:

• Medical Mycology
• Molecular Biology
• Diagnostic Microbiology

Background:

• The Candida parapsilosis complex includes closely related species vital for clinical identification.
• Accurate differentiation of these species is crucial for effective antifungal treatment and epidemiological studies.
• Existing methods may not always provide rapid or definitive species-level identification within the complex.

Purpose of the Study:

• To develop a molecular method for reliable differentiation of species within the Candida parapsilosis complex.
• To establish a technique that can distinguish Candida parapsilosis sensu stricto, Candida orthopsilosis, Candida metapsilosis, and Lodderomyces elongisporus.
• To provide a tool for improved diagnostic accuracy in clinical mycology.

Main Methods:

• Development of an exon-primed intron-crossing PCR (EPIC-PCR) assay.
• Utilizing distinct amplicon sizes generated by PCR for species differentiation.
• Employing restriction enzyme analysis for further discrimination between Candida orthopsilosis and Candida metapsilosis.

Main Results:

• The EPIC-PCR assay successfully differentiated the members of the Candida parapsilosis complex based on unique amplicon sizes.
• Restriction enzyme analysis provided clear discrimination between Candida orthopsilosis and Candida metapsilosis.
• The developed methods offer a reliable way to identify individual species within this complex.

Conclusions:

• The exon-primed intron-crossing PCR assay is a valuable tool for distinguishing species within the Candida parapsilosis complex.
• Combined with restriction enzyme analysis, this molecular approach offers high discriminatory power.
• This methodology can significantly aid in the accurate identification of Candida species in clinical settings.